Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06140056
Other study ID # H-23050947
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 8, 2023
Est. completion date November 1, 2026

Study information

Verified date May 2024
Source University Hospital Bispebjerg and Frederiksberg
Contact Theis Itenov, Md, PhD
Phone +4551341945
Email theis.skovsgaard.itenov@regionh.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study examines individuals admitted to the intensive care unit due to breathing difficulties resulting in not getting enough oxygen into their bodies. These patient will receive mechanical ventilation and this study aims to determine how the pressure inside the lungs changes when using two different modes of mechanical ventilation. The goal is to improve management and care of breathing difficulties by gaining insight into changes in lung pressure during mechanical ventilation, as well as comparing the effectiveness of the two ventilator modes.


Description:

As hypoxic respiratory failure is an acute condition, this trial will enrol temporarily incompetent patients and obtain consent from the patient's next of kin and an independent medical doctor (trial guardian) as soon as possible after enrolment. When included in the study, patients will be randomized 1:1 centrally in the RedCap system, using a computer-generated concealed assignment sequence, with permuted blocks of varying sizes, to start with either the intervention (APRV) followed by control (volume controlled mechanical ventilation) or control followed by intervention. Esophageal manometry will be used as a surrogate to measure the transpulmonary pressure. Arterial blood gasses, blood samples and lung ultrasound will be used to investigate oxygenation, ventilation and aeration. Treatment targets for both groups during the study are pH >7.20, saturation ≥ 88% and PaO2 ≥ 8.0 kPa, with FiO2 titrated as low as possible while complying to the oxygenation targets (PaO2 and saturation). Both arms start with an 'adjustment phase' where the ventilator is adjusted so the respiratory values are within the targets. The intervention adjustment phase is at least 30 minutes. The adjustments will follow standardized protocols. When the respiratory values are within range, the 'observation period begins' and no changes are made to the ventilator for 3 hours, unless it is necessary to achieve ventilatory treatment targets or deemed necessary by the treating physician. During the trial, the patient must be positioned in a supine position with the headboard elevated 0-30 degrees. After the first 'observation period', the patient is switched to the opposite ventilation mode and will go through an 'adjustment phase' and 'observation period' again. Once a patient regains competence, they will be provided with both written and oral information regarding the trial By comparing volume controlled mechanical ventilation and APRV and their transpulmonary pressures, valuable insight can be gained regarding optimal ventilation strategy for patients with hypoxic respiratory failure. Understanding how various ventilation modes influence transpulmonary pressure and their potential effects on respiratory mechanics can potentially inform designs of trials with individualized respiratory care.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date November 1, 2026
Est. primary completion date November 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Admitted to the ICU - Invasive mechanical ventilation with FiO2 = 50% OR PaO2-to-FiO2 ratio <20 kPa, including PEEP 3 5 cmH20 for at least 6 hours Exclusion Criteria: - Meeting inclusion criteria for more than 24 hours - Severe bronchospasm, defined as warranting treatment aimed at reversing this i.e. inhalation of anticholinergic or bronchodilator beyond what the patient normally use - Emphysema where treating physician judges the patient at increased risk for pneumothorax from APRV - Restrictive lung disease defined as a pre-admission diagnosis of restrictive lung disease - Undrained pneumothorax - Hemodynamic instability defined as more than 0.20 microgram/kg/min of norepinephrine or any dose of adrenaline infusion to maintain MAP = 65 mmHg - Age < 18 years - Patients who have received APRV previously during the current ICU admission - Patients in prone position within the last 24 hours

Study Design


Intervention

Other:
Airway pressure release ventilation
Mechanical ventilation mode
Volumen controlled mechanical ventilation
Mechanical ventilation mode

Locations

Country Name City State
Denmark Hvidovre Hospital Hvidovre
Denmark Bispebjerg Hospital København

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Bispebjerg and Frederiksberg

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Proportion of patients unable to tolerate observation period without increasing ventilator settings Defined as measures aimed at increasing either oxygenation or ventilation During observation period; 1-6 hours after randomization
Primary Median peak transpulmonary pressure Measured with esophageal manometry in cmH20. During the observation period; 1-6 hours after randomization
Secondary Proportion of patients with peak transpulmonary pressure > 12 cmH2O Measured with esophageal manometry During observation period; 1-6 hours after randomization
Secondary Change in peak transpulmonary pressure in cmH20 Measured with esophageal manometry. Calculated as beginning - end of observation period During observation period; 1-6 hours after randomization
Secondary Fluctuations in transpulmonary pressure in cmH20 Measured with esophageal manometry. Difference between peak and nadir transpulmonary pressure during respiratory cycle During observation period; 1-6 hours after randomization
Secondary Change in fluctuations of transpulmonary pressure in cmH20 Measured with esophageal manometry. Calculated as beginning - end of observation period. During observation period; 1-6 hours after randomization
Secondary Nadir PaO2-to-FiO2 ratio Calculated by PaO2/FiO2. PaO2 from arterial blood gasses and FiO2 from ventilator setting During observation period; 1-6 hours after randomization
Secondary Peak FiO2 in % FiO2 from ventilator settings During observation period; 1-6 hours after randomization
Secondary Peak PaCO2 in kPa PaCO2 from arterial blood gasses During observation period; 1-6 hours after randomization
Secondary Nadir pH pH from arterial blood gasses During observation period; 1-6 hours after randomization
Secondary Lung ultrasound aeration according to LUS Evaluating lung aeration by Lung Ultrasound Score During observation period; 1-6 hours after randomization
See also
  Status Clinical Trial Phase
Completed NCT05161962 - Oral Care to Prevent Ventilator-associated Pneumonia N/A
Terminated NCT02903407 - Pain, Agitation and Delirium (PAD) Protocol in the Duke CICU Phase 4
Enrolling by invitation NCT04520893 - Ventilation Strategy for the Elderly Patients in Prone Position N/A
Completed NCT03180203 - Postoperative INTELLiVENT-ASV Ventilation N/A
Completed NCT03497559 - Music Use for Sedation In Critically Ill Children N/A
Recruiting NCT03439683 - KAP Asynchrony Survey
Recruiting NCT05270018 - Bacterial Lysates on Respiratory Tract Microecology and Evaluation of the Efficacy of Prevention and Treatment of VAP N/A
Recruiting NCT04841746 - Efficacy of FES Cycling After a Severe Form of COVID-19 N/A
Not yet recruiting NCT06468436 - Dexmedetomidine-Esketamine Combination for Sedation and Analgesia in ICU Patients N/A
Recruiting NCT04731532 - Comparison of Thoracic Vibration With Classical Respiratory Physiotherapy in Patients With Mechanical Ventilation N/A
Not yet recruiting NCT06147674 - Evaluation of VQm PHM on Pulmonary Health Parameters for ICU
Enrolling by invitation NCT05759013 - Pivotal Evaluation of Abdominal Neuromuscular Electrical Stimulation (VentFree) for Weaning From Mechanical Ventilation N/A
Completed NCT02989246 - Effort of Breathing Guided Ventilator Protocol N/A
Completed NCT00211016 - Doripenem in the Treatment of Ventilator-Associated Pneumonia Phase 3
Recruiting NCT03376711 - Development & Pilot RCT of an Online Peer Support Program for Family Caregivers of Ventilator-Assisted Individuals N/A